In this study, we unraveled the crucial role of an interaction between H19-YB-1 in regulating cardiac fibrosis after infarction and demonstrated that lncRNA H19 is an ECM regulator which may serve as a therapeutic target for ischemic cardiomyopathy. The gene discussed is H19; the disease is fibrosis.